Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Completed

α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD

NCT03188601

Conditions
Alpha 1-Antitrypsin, Bone Marrow Transplant Failure, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hadassah Jerusalem, Center, Israel
  • Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv, Center, Israel
  • Rambam MC Haifa, North, Israel
  • Soroka Medical Center Beersheba, South, Israel
View Trial Details
Completed

Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.

NCT03470857

Conditions
Antioxidants, Ceroid Lipofuscinosis, Neuronal, 10, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations
  • The Chair of Medical Biology, Collegium Medicum of Nicolaus Copernicus University Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • Department of Nuclear Medicine of Center Oncology in Bydgoszcz Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • Department of Positron Emission Tomography and Molecular Diagnostics, Collegium Medicum of Nicolaus Copernicus University Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
View Trial Details
Completed

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

NCT03815396

Conditions
AATD, Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • UC Davis School of Medicine Sacramento, California, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Indiana University Indianapolis, Indiana, United States
View Trial Details
Completed

Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype

NCT04474197

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 30 locations
View Trial Details
Completed

A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.

NCT03636347

Conditions
Alpha 1-Antitrypsin Deficiency, COPD, Chronic Disease, +14 more
Locations
  • University of Alabama, Birmingham (UAB) Birmingham, Alabama, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UC Davis Medical Centre Sacramento, California, United States
  • PMG Research of Wilmington Wilmington, North Carolina, United States
View all 26 locations
View Trial Details
Completed

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study

NCT02525861

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Arizona Board of Regents, University of Arizona Tucson, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Cedars Sinai Medical Center, Division of Pulmonary and Critical Care Medicine Los Angeles, California, United States
  • University of California Davis Health System Sacramento, California, United States
View all 18 locations
View Trial Details
Completed

GLASSIA Infusion Rate Study

NCT01651351

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +11 more
Locations
  • Overland Park, Kansas, United States
View Trial Details

Related conditions